May 14, 2019 / 01:00PM GMT
Operator
Good morning, and welcome to the Onconova Therapeutics Corporate Update and First Quarter 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this call may be recorded.
At this time, I'd like to turn the call over to Avi Oler, Vice President of Corporate Development and General Counsel at Onconova.
Abraham N. Oler - Onconova Therapeutics, Inc. - VP of Corporate Development & General Counsel
Thank you, operator. Good morning, and welcome to Onconova's Corporate Update and -- First Quarter 2019 Corporate Update and First Quarter Financial Results Conference Call. Earlier this morning, we issued a press release with first quarter 2019 financial results and business updates. If you have not seen this morning's earnings release, you can find it on our Investor Relations page of our website at www.onconova.com.
On today's call, Dr. Steve Fruchtman, President and Chief Executive officer, will review the company's recent business and clinical highlights and
Q1 2019 Onconova Therapeutics Inc Earnings Call Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers